Wells Fargo’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $683 | Hold |
330
| – | – | ﹤0.01% | 5884 |
|
|
2025
Q1 | $554 | Hold |
330
| – | – | ﹤0.01% | 5795 |
|
|
2024
Q4 | $726 | Hold |
330
| – | – | ﹤0.01% | 5783 |
|
|
2024
Q3 | $492 | Hold |
330
| – | – | ﹤0.01% | 5763 |
|
|
2024
Q2 | $653 | Sell |
330
-104
| -24% | -$206 | ﹤0.01% | 5739 |
|
|
2024
Q1 | $1.33K | Buy |
434
+43
| +11% | +$132 | ﹤0.01% | 5698 |
|
|
2023
Q4 | $2.71K | Buy |
391
+334
| +586% | +$2.31K | ﹤0.01% | 5605 |
|
|
2023
Q3 | $195 | Buy |
57
+15
| +36% | +$51 | ﹤0.01% | 6219 |
|
|
2023
Q2 | $113 | Buy |
42
+4
| +11% | +$11 | ﹤0.01% | 6531 |
|
|
2023
Q1 | $69 | Buy |
38
+1
| +3% | +$2 | ﹤0.01% | 6702 |
|
|
2022
Q4 | $85 | Buy |
37
+1
| +3% | +$2 | ﹤0.01% | 6508 |
|
|
2022
Q3 | $0 | Sell |
36
-34
| -49% | – | ﹤0.01% | 6643 |
|
|
2022
Q2 | $0 | Buy |
70
+44
| +169% | – | ﹤0.01% | 6803 |
|
|
2022
Q1 | $0 | Buy |
+26
| New | – | ﹤0.01% | 6924 |
|